Diagnostic Performance of Serum Asialo α1-Acid Glycoprotein Levels to Predict Liver Cirrhosis
Autor: | Ho Soon Choi, Dae Won Jun, Mimi Kim, Kang Nyeong Lee, Byung Chul Yoon, Oh Young Lee, Bo Kyeong Kang, Dae Hyun Lim, Hang Lak Lee, Jai Hoon Yoon, Min Jung Kwak |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Cirrhosis Hepatology business.industry Bilirubin Gastroenterology Area under the curve α 1 acid glycoprotein medicine.disease Chronic liver disease 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Chronic hepatitis chemistry Liver stiffness 030220 oncology & carcinogenesis Internal medicine Medicine 030211 gastroenterology & hepatology Ultrasonography business |
Zdroj: | Gut and Liver. 15:109-116 |
ISSN: | 2005-1212 1976-2283 |
Popis: | Background/Aims: To date, studies on various noninvasive techniques have been suggested to evaluate the degree of liver fibrosis. We aimed to investigate the diagnostic performance of serum asialo α1-acid glycoprotein (AsAGP) in the diagnosis of liver cirrhosis compared with chronic hepatitis for clinically useful result. Methods: We conducted a case-control study of 96 patients with chronic liver disease. Chronic hepatitis was defined as the presence of chronic liver disease on ultrasonography, with a liver stiffness of less than 5.0 kPa as shown on magnetic resonance elastography (MRE). Liver cirrhosis was defined as liver stiffness of more than 5.0 kPa on MRE. The serum AsAGP concentration was compared between the two groups. Results: Serum AsAGP levels were significantly higher in patients with cirrhosis than in those with chronic hepatitis (1.83 μg/mL vs 1.42 μg/mL, p |
Databáze: | OpenAIRE |
Externí odkaz: |